Basit öğe kaydını göster

Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control

dc.contributor.authorGurdol, Figen
dc.contributor.authorUnlucerci, Yesim
dc.contributor.authorBekpinar, Seldağ
dc.contributor.authorTutuncu, Yıldız
dc.contributor.authorDinccag, Nevin
dc.contributor.authorCan, Ayten
dc.date.accessioned2021-03-04T14:24:31Z
dc.date.available2021-03-04T14:24:31Z
dc.date.issued2011
dc.identifier.citationCan A., Bekpinar S., Gurdol F., Tutuncu Y., Unlucerci Y., Dinccag N., "Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control", DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.94, sa.3, 2011
dc.identifier.issn0168-8227
dc.identifier.otherav_815ef13d-a6fa-460c-895f-005fbe6d6ba8
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/88180
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2011.08.008
dc.description.abstractWe tested the relationship between plasma levels of dimethylarginines (ADMA and SDMA) and glycaemic control in 43 type 2 diabetic patients. Type 2 diabetics with poor glycaemic control (HbA1c > 6.5) had significantly lower SDMA and higher ADMA concentrations than those with well-controlled glycaemia (HbA1c < 6.5). (C) 2011 Elsevier Ireland Ltd. All rights reserved.
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.titleDimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
dc.typeMakale
dc.relation.journalDIABETES RESEARCH AND CLINICAL PRACTICE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume94
dc.identifier.issue3
dc.contributor.firstauthorID29770


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster